Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,975
Total Claims
$1.4M
Drug Cost
236
Beneficiaries
$6,134
Cost/Patient
Risk Score Breakdown 14/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+753%
Cost per patient vs peers
$6,134 vs $719 avg
+1058%
Brand preference vs peers
77.0% vs 6.7% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Brand vs Generic
Brand: 1,264 claims · $1.3M
Generic: 377 claims · $8,821
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 111 | $148K |
| Semaglutide | 101 | $138K |
| Insulin Aspart | 97 | $117K |
| Insulin Lispro | 77 | $111K |
| Insulin Pump Cart,automated,bt | 77 | $98K |
| Insulin Lispro | 84 | $81K |
| Insulin Degludec | 57 | $63K |
| Insulin Glargine,hum.Rec.Anlog | 38 | $59K |
| Insulin Aspart | 25 | $48K |
| Liraglutide | 18 | $43K |
| Insulin Glargine,hum.Rec.Anlog | 60 | $39K |
| Insulin Lispro | 13 | $39K |
| Insulin Glargine,hum.Rec.Anlog | 74 | $39K |
| Insulin Degludec | 72 | $38K |
| Insulin Lispro-Aabc | 26 | $37K |
Prescribing Profile
Patient Profile
69
Avg Age
64%
Female
1.68
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About